share_log

Invivyd | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Invivyd | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Invivyd | S-8：員工福利計劃證券登記
美股sec公告 ·  05/10 04:50
牛牛AI助理已提取核心訊息
On May 9, 2024, Invivyd, Inc., a biotechnology company based in Waltham, Massachusetts, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC). The filing is intended to register an additional 3,304,820 shares of common stock under the company's 2021 Equity Incentive Plan. This move follows the provisions of the 2021 Plan, which allows for an automatic increase in the number of shares reserved for issuance each year. The newly registered shares are set to support the company's equity incentive efforts, aimed at attracting and retaining talent. Invivyd, Inc. has incorporated by reference its previous filings, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other relevant documents. The company, identified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has also included various exhibits and legal opinions in the registration statement.
On May 9, 2024, Invivyd, Inc., a biotechnology company based in Waltham, Massachusetts, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC). The filing is intended to register an additional 3,304,820 shares of common stock under the company's 2021 Equity Incentive Plan. This move follows the provisions of the 2021 Plan, which allows for an automatic increase in the number of shares reserved for issuance each year. The newly registered shares are set to support the company's equity incentive efforts, aimed at attracting and retaining talent. Invivyd, Inc. has incorporated by reference its previous filings, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other relevant documents. The company, identified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has also included various exhibits and legal opinions in the registration statement.
2024年5月9日，總部位於馬薩諸塞州沃爾瑟姆的生物技術公司Invivyd, Inc. 向美國證券交易委員會（SEC）提交了S-8表格的註冊聲明。該文件旨在根據公司的2021年股權激勵計劃再註冊3,304,820股普通股。此舉遵循了2021年計劃的規定，該計劃允許每年自動增加預留髮行的股票數量。新註冊的股票將支持公司的股權激勵工作，旨在吸引和留住人才。Invivyd, Inc.以引用方式納入了其先前提交的文件，包括截至2023年12月31日財年的10-K表年度報告和其他相關文件。該公司被認定爲非加速申報人、小型申報公司和新興成長型公司，還在註冊聲明中納入了各種證物和法律意見。
2024年5月9日，總部位於馬薩諸塞州沃爾瑟姆的生物技術公司Invivyd, Inc. 向美國證券交易委員會（SEC）提交了S-8表格的註冊聲明。該文件旨在根據公司的2021年股權激勵計劃再註冊3,304,820股普通股。此舉遵循了2021年計劃的規定，該計劃允許每年自動增加預留髮行的股票數量。新註冊的股票將支持公司的股權激勵工作，旨在吸引和留住人才。Invivyd, Inc.以引用方式納入了其先前提交的文件，包括截至2023年12月31日財年的10-K表年度報告和其他相關文件。該公司被認定爲非加速申報人、小型申報公司和新興成長型公司，還在註冊聲明中納入了各種證物和法律意見。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。